Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when ...

CHI Memorial is proud to announce it is the first hospital in the world to enroll a patient in a Phase 3 clinical trial evaluating a promising new treatment for ischemic stroke. This groundbreaking ...

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced that the U.S. Food and Drug Administration has granted Fast ...

A research team led by Professor Lee Kyung-yeol and Jeong Yo-han of Yonsei University's Gangnam Severance Hospital confirmed ...

DelveInsight’s, “Ischemic Stroke Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 55+ ...

UT Dell Medical School study helps solve question of when to start blood thinners after a stroke in someone with AFib.

Exogenous inter-α inhibitor proteins prevent cell death and improve ischemic stroke outcomes in mice. Journal of Clinical Investigation, 2021; 131 (17) DOI: 10.1172/JCI144898 ...

Ischemia-Reperfusion-induced GAPDH aggregates lead to cell death and paralysis, but both GAPDH-C152A expression and GAI-17 ...

DiaMedica’s lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of acute ...

Berhampur: Prompt intervention by doctors at MKCG Medical College and Hospital here helped save a 49-year-old assistant ...

Acute ischemic stroke remains one of medicine’s most time-sensitive emergencies. When blood flow to the brain becomes blocked, approximately 1.9 million neurons die each minute without intervention.

We divide the term stroke into two general categories: ischemic and hemorrhagic. Ischemic Stroke An ischemic stroke is a clot-based stroke that forms in the brain or elsewhere in the body and blocks ...